-
Je něco špatně v tomto záznamu ?
Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer
V. Hanusova, P. Matouskova, M. Manethova, J. Soukup, S. John, M. Zofka, H. Vošmikova, L. Krbal, E. Rudolf
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- epitelo-mezenchymální tranzice genetika MeSH
- kolorektální nádory * patologie MeSH
- lidé MeSH
- mikro RNA * genetika metabolismus MeSH
- nádory rekta * MeSH
- nádory tračníku * genetika MeSH
- regulace genové exprese u nádorů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Colorectal cancer (CRC) is the fourth most commonly diagnosed malignant condition in the world. Micro RNAs (miRNAs) as well as epithelial to mesenchymal transition (EMT) play an important role in the pathogenesis of CRC. We performed a comparative analysis of the expression of selected miRNA genes and EMT markers in bioptic samples from patients (n = 45) with primary CRC or metastatic (m)CRC to the regional lymph node using reverse transcription-quantitative PCR and IHC staining. Results: Out of all miRNA analyzed, the miR-17 expression was most significantly different and associated with lower risk of CRC spread to the lymph node. In addition, significant relationships were found between the tumor side localization and several miRNAs expressions (miR-9, miR-29b, miR-19a, miR-19b, miR-21, miR-106a, miR-20a and miR-17). In addition, of the examined EMT markers, only VEGFA expression correlated with tumor progression (tumor grade G2). In the examined set of patient samples and their matched healthy tissue, several specific molecular markers (miRNAs associated with EMT and tumor progression) were identified with a promising prognostic potential. Their further examination in larger patient cohorts is planned to validate the present data.
Department of Biochemistry Faculty of Pharmacy Charles University Czech Republic
Department of Medical Biology and Genetics Faculty of Medicine Charles University Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007884
- 003
- CZ-PrNML
- 005
- 20240423160346.0
- 007
- ta
- 008
- 240412s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/07357907.2023.2283495 $2 doi
- 035 __
- $a (PubMed)37997798
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hanusova, Veronika $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University, Czech Republic
- 245 10
- $a Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer / $c V. Hanusova, P. Matouskova, M. Manethova, J. Soukup, S. John, M. Zofka, H. Vošmikova, L. Krbal, E. Rudolf
- 520 9_
- $a Colorectal cancer (CRC) is the fourth most commonly diagnosed malignant condition in the world. Micro RNAs (miRNAs) as well as epithelial to mesenchymal transition (EMT) play an important role in the pathogenesis of CRC. We performed a comparative analysis of the expression of selected miRNA genes and EMT markers in bioptic samples from patients (n = 45) with primary CRC or metastatic (m)CRC to the regional lymph node using reverse transcription-quantitative PCR and IHC staining. Results: Out of all miRNA analyzed, the miR-17 expression was most significantly different and associated with lower risk of CRC spread to the lymph node. In addition, significant relationships were found between the tumor side localization and several miRNAs expressions (miR-9, miR-29b, miR-19a, miR-19b, miR-21, miR-106a, miR-20a and miR-17). In addition, of the examined EMT markers, only VEGFA expression correlated with tumor progression (tumor grade G2). In the examined set of patient samples and their matched healthy tissue, several specific molecular markers (miRNAs associated with EMT and tumor progression) were identified with a promising prognostic potential. Their further examination in larger patient cohorts is planned to validate the present data.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kolorektální nádory $x patologie $7 D015179
- 650 _2
- $a epitelo-mezenchymální tranzice $x genetika $7 D058750
- 650 12
- $a mikro RNA $x genetika $x metabolismus $7 D035683
- 650 12
- $a nádory tračníku $x genetika $7 D003110
- 650 12
- $a nádory rekta $7 D012004
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Matouskova, Petra $u Department of Biochemistry, Faculty of Pharmacy, Charles University, Czech Republic
- 700 1_
- $a Manethova, Monika $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Soukup, Jiri $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a John, Stanislav $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University, Czech Republic $u The Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Zofka, Martin $u Department of Biochemistry, Faculty of Pharmacy, Charles University, Czech Republic
- 700 1_
- $a Vošmikova, Hana $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Krbal, Lukas $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Rudolf, Emil $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University, Czech Republic
- 773 0_
- $w MED00007151 $t Cancer investigation $x 1532-4192 $g Roč. 41, č. 10 (2023), s. 837-847
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37997798 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160342 $b ABA008
- 999 __
- $a ok $b bmc $g 2081723 $s 1217651
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 41 $c 10 $d 837-847 $e 20240102 $i 1532-4192 $m Cancer investigation $n Cancer Invest $x MED00007151
- LZP __
- $a Pubmed-20240412